Meeting
2021 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) as a tool to help guide germline testing in patients with solid malignancies.
Authors
Nikita Pankaj Patel
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Nikita Pankaj Patel , Ami N. Shah , Andrew A. Davis , Lorenzo Gerattana , Saya Jacob , Neelima Katam , Firas Hazem Wehbe , Amir Behdad , Theresa Sciaraffa , Massimo Cristofanilli
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10602)
DOI
10.1200/JCO.2021.39.15_suppl.10602
Abstract #
10602
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
First Author: Charité Ricker
Poster
2023 ASCO Annual Meeting
ctDNA detection in patients with brain metastases arising from solid tumors.
First Author: Laura Alder
Poster
2023 ASCO Annual Meeting
Analysis of ATM germline mutations in solid tumors from Chinese patients.
First Author: Tao Fu
Poster
2023 ASCO Annual Meeting
Impact of pathogenic germline BRCA1/2 and PALB2 mutations and tumor aneuploidy in patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors.
First Author: Jesús Fuentes Antrás